Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page
Amazing that no one has offered any insight here. I have been a BIIB shareholder since the trading symbol has been BIIB. The silence here is beyond scary! TK was/is an exceptional talent and leader. I am seriously concerned about what will happen to the stock when the Q3 results are announced. Any one else?
It's very scary that not a word has been said about TK's departure & that it occurred so swiftly. This company has declined as rapidly as it ascended during the Tec launch. Concerned with all of us who are employed here & with what will happen next. Truly, does anyone know anything about TK leaving??
Are you people insane? TK is the reason we are in this mess! He brought in this horrendous senior management team who have run this biotech into the ground in 2 years!
Are you people insane? TK is the reason we are in this mess! He brought in this horrendous senior management team who have run this biotech into the ground in 2 years!